SAN FRANCISCO, CA, August 09, 2010 (Press-News.org) Lampire Biological Laboratories (LBL) announced today that it signed an agreement with Proliant Health and Biologicals (Proliant), manufacturer of the worlds most trusted, high quality Bovine Serum Albumin (BSA), to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.
Stephen Welch, President & CEO of Proliant, said, "Proliant has become the pre-eminent bulk manufacturer of BSA, currently supplying over half of global demand. As part of this rapid growth, Proliant is committed to supplying customers who require smaller quantities of BSA the same value large scale customers enjoy, plus a greater degree of flexibility and customer service." Stephen went on to say, "The search is now over; Lampire with its contract manufacturing abilities, plus an extensive knowledge of the diagnostic and pharmaceutical industries, fulfills every attribute Proliant requires."
According to Gregory F. Krug, President & CEO of LBL, "The applications for BSA are truly endless and we are proud to enter into this strategic partnership with Proliant." Greg went on to say, "...we are looking at drug development labs, academic research institutes, biotech companies and antibody suppliers all of which need high quality BSA. The Lampire Business Model will allow us to provide them with high quality BSA in a variety of forms and formulations in a most cost-effective manner."
About Lampire Biological Laboratories
Lampire Biological Laboratories specializes in polyclonal and monoclonal antibody development, cell culture devices and services, and a wide variety of blood-derived products. Founded in 1977, the Pennsylvania based company offers an extensive line of secondary antibodies, purified IgGs, human and animal blood products, plus a comprehensive line of animal tissues and organs. The latest product and service releases include novel teratogenicity screening assays, New Zealand sourced animal blood products, the gas-permeable LAMPIRE OMNI C3 Cell Culture Bag, exclusive antibodies to chemotherapeutic agents, and Proliant BSA. Additional services include peptide synthesis, antigen design, antibody purification, custom conjugation, immunoassay development, and contract manufacturing. Lampire is a privately held company.
About Proliant Health and Biologicals
Proliant, a privately held company, is the world's largest producer of bovine plasma derivatives, such as BSA. Derived from the plasma of healthy, US-origin animals with complete traceability, Proliant's bovine serum albumin exceeds 99% purity and is suitable for diagnostic, pharmaceutical, veterinary, and research applications.
Proliant Health and Biologicals specializes in the development of ingredients from natural sources for the human health and nutrition industry, including the dietary supplement, clinical nutrition, consumer health and functional food markets. Proliant has developed exciting new technologies to isolate bio-active proteins and peptides that play vital roles in human health. The most well-known of these are immunoglobulins.
Proliant ingredients are unsurpassed in innovation and quality, which allows them to be used in the most sensitive nutritional applications. ImmunoLin is an immunoglobulin protein isolate which can be used for tablets, capsules, drink mixes, lozenges and bars.
Contacts:
Lampire Biological Laboratories
Gregory F. Krug
President
Office: 215-795-2838
Website: http://www.proliantinc.com
or
Proliant Health & Biologicals
Jim Torvik
Director of Sales and Marketing
Office: 515-289-5142
Mobile: 515-494-0700
Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin
This partnership will meet market needs with quality, value and flexibility.
2010-08-09
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Whataburger Asks Customers: "Tell Us Why You're Our Biggest Fan!"
2010-08-09
Southern burger icon Whataburger celebrates its 60th anniversary with its "Tell Us Why You're Our Biggest Fan" online contest. At stake is a Whataburger fan's dream come true: 60 years of free Whataburger, a trip to the Whataburger convention in Dallas, TX and other cool prizes!
Beginning August 4 and all throughout the company's anniversary month of August, fans can submit either videos or essays with photos at www.whataburger.com, demonstrating why they are Whataburger's biggest fans. The first 60 fans to enter will win a coupon for a free Whataburger.
The contest ...
LAST 30 PRESS RELEASES:
How rice plants tell head from toe during early growth
Scientists design solar-responsive biochar that accelerates environmental cleanup
Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases
Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy
DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer
Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model
Neg-entropy is the true drug target for chronic diseases
Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis
Early TB treatment reduced deaths from sepsis among people with HIV
Palmitoylation of Tfr1 enhances platelet ferroptosis and liver injury in heat stroke
Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity
Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guidelines
New global review reveals integrating finance, technology, and governance is key to equitable climate action
New study reveals cyanobacteria may help spread antibiotic resistance in estuarine ecosystems
Around the world, children’s cooperative behaviors and norms converge toward community-specific norms in middle childhood, Boston College researchers report
How cultural norms shape childhood development
University of Phoenix research finds AI-integrated coursework strengthens student learning and career skills
Next generation genetics technology developed to counter the rise of antibiotic resistance
Ochsner Health hospitals named Best-in-State 2026
A new window into hemodialysis: How optical sensors could make treatment safer
High-dose therapy had lasting benefits for infants with stroke before or soon after birth
‘Energy efficiency’ key to mountain birds adapting to changing environmental conditions
Scientists now know why ovarian cancer spreads so rapidly in the abdomen
USF Health launches nation’s first fully integrated institute for voice, hearing and swallowing care and research
Why rethinking wellness could help students and teachers thrive
Seabirds ingest large quantities of pollutants, some of which have been banned for decades
When Earth’s magnetic field took its time flipping
Americans prefer to screen for cervical cancer in-clinic vs. at home
Rice lab to help develop bioprinted kidneys as part of ARPA-H PRINT program award
Researchers discover ABCA1 protein’s role in releasing molecular brakes on solid tumor immunotherapy
[Press-News.org] Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum AlbuminThis partnership will meet market needs with quality, value and flexibility.